Trial intelligence / Profile preview

Carvedilol versus ramipril for cardioprotection in Duchenne and Becker muscular dystrophy

2008-007236-18Phase 4Terminated

Sponsor
Policlinico Gemelli
Start
Dec 2008
Modality
Small Molecules
Countries
1
01

Overview

Phase 4 trial of carvedilol and ramipril in Duchenne muscular dystrophy (DMD) and Becker muscular dystrophy (BMD) (2 arms), sponsored by Policlinico Gemelli. Primary endpoints: Left ventricular ejection fraction, Left ventricular systolic volume and 3 more. Started Dec 2008; status: terminated.

02

Drugs

carvedilolramipril
03

Conditions

Duchenne muscular dystrophy (DMD)Becker muscular dystrophy (BMD)

Beyond the preview

Go deeper on 2008-007236-18.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2008-007236-18.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call